The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
857
Pitavastatin once daily
Simvastatin once daily
Percent Change From Baseline in Low Density Lipoprotein-cholesterol (LDL-C) at 12 Weeks
Percent change from baseline in low density lipoprotein-cholesterol (LDL-C)after 12 Weeks
Time frame: Baseline to 12 weeks
National Cholesterol Education Program (NCEP) LDL-C Target Attainment
Number of subjects achieving National Cholesterol Education Program (NCEP) LDL-C Target (LDL less than or equal to 130 mg/dL)at Week 12
Time frame: 12 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Geri-Med Oy
Helsinki, Finland
Kaisaniemen Laakariasema
Helsinki, Finland
Keravan Laakarikeskus
Helsinki, Finland
SOK-tyoterveyshuolto
Tampere, Finland
TYKS University Hospital
Turku, Finland
Dipartimento Di Medicina Clinica e Biotecnologia Applicata
Bologna, Italy
Centro di Ricerca Clinica
Chieti, Italy
Gerontologia e Geriatria - Universita degli Studi
Ferrara, Italy
Dipartimento di Medicina Interna DIMI
Genova, Italy
Universita di Modena e Reggio Emilia, Policlinico
Modena, Italy
...and 32 more locations